Clinical efficacy and safety of anlotinib versus anlotinib combined with regimen on multi-line treatments of elderly patients with gastrointestinal tumors

Yang Lifei; Lu Pengfei; Liu Junyuan; Shan Li; Ma Ling

doi:10.3760/j.issn.1673-4777.2022.05.011

Home>Articles>Clinical efficacy and safety of anlotinib versus anlotinib combined with regimen on multi-line treatments of elderly patients with gastrointestinal tumors

DOI: 10.3760/j.issn.1673-4777.2022.05.011

Clinical efficacy and safety of anlotinib versus anlotinib combined with regimen on multi-line treatments of elderly patients with gastrointestinal tumors

Yang Lifei

Lu Pengfei

Liu Junyuan

Shan Li

Ma Ling

Machine-generated Keywords：

Publication Date：2022-05-08

Online Publishing Date：2026-09-14(First online date of this platform, not the publication date of the document)

Pages：4( 688-691 )

China Medicine

ISTIC

ISSN：1673-4777

Year, Vol.(Issue)：2022,17(5)